November 9, 2021
Tag: Charles Perou
![Headshot of William Kim](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/cancer-genomics-with-cognitive-computing-image2-600x400.jpeg)
August 16, 2021
Experimental drug that boosts immunotherapy shows promise in bladder cancer study
William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.
![Exteriors of the UNC Lineberger and Marsico Hall buildings](https://unclineberger.org/wp-content/uploads/sites/867/2021/12/Lineberger-Marsico-exterior-600x400.jpg)
May 11, 2021
Celebrating nearly 15 centuries of service
The University of North Carolina at Chapel Hill is recognizing 118 UNC Lineberger staff and faculty members who will be celebrating a service milestone this year.
![A scientist in a lab holds up a vial filled with bright purple liquid. The scientist is wearing glasses and latex gloves, and holds the vial up to examine it.](https://unclineberger.org/wp-content/uploads/sites/867/2020/11/research-lab-purple-liquid-600x400.jpg)
November 20, 2020
UNC Lineberger faculty among the most highly cited scientists worldwide
Clarivate’s 2020 Highly Cited Researchers list recognized 15 UNC Lineberger members for publishing some of the most influential scientific papers the past decade.
![AACR award logo with headshots of Lineberger faculty award recipients](https://unclineberger.org/wp-content/uploads/sites/867/2020/06/AACR-team-award-winners-Lineberger-2020-600x400.jpg)
June 24, 2020
AACR honors The Cancer Genome Atlas researchers with 2020 Team Science Awards
UNC Lineberger faculty have held leadership and team membership roles with The Cancer Genome Atlas, which was launched in 2006.
![](https://unclineberger.org/wp-content/uploads/sites/867/2019/09/careyfrancoperou.jpg)
September 16, 2019
Susan G. Komen awards nearly $1.5M in breast cancer research grants to UNC Lineberger
Susan G. Komen® today announced it was providing $1.45 million in research grants to three UNC Lineberger Comprehensive Cancer Center members as part of a national campaign focused on metastatic breast cancer, developing new, more-effective treatments, and addressing disparities in breast cancer outcomes. The grants support Komen’s commitment to achieve its Bold Goal to reduce …
![](https://unclineberger.org/wp-content/uploads/sites/867/2019/04/Liu-Earp-528x400.jpg)
April 19, 2019
Study provides insights behind hyperactivation of key cell proliferation signal
The idea was simple: find the faulty signals that drive cancerous growth in cells, and block them. But what University of North Carolina Lineberger Comprehensive Cancer Center researcher Pengda Liu, PhD, has discovered, when it comes to cancer, even straightforward concepts can become complicated. “When you find a target and inhibit it, you find the …
![Charles M. Perou, Melissa Troester, and Heather D. Couture](https://unclineberger.org/wp-content/uploads/sites/867/2018/11/peroutro-ester-couture-600x400.jpg)
November 19, 2018
Scientists train a computer to classify breast cancer tumors
Using technology similar to the type that powers facial recognition on a smartphone, Charles M. Perou, PhD, Melissa Troester, PhD, and Heather D. Couture have trained a computer to analyze breast cancer images and then classify the tumors with high accuracy.
![UNC Lineberger's Qing Zhang, PhD, an assistant professor in the UNC School of Medicine Department of Pathology & Laboratory Medicine and Pharmacology.](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/kidney-cancer-driver-could-lead-to-new-treatment-strategy-image2-600x400.jpeg)
July 19, 2018
Discovery of kidney cancer driver could lead to new treatment strategy
In a study published in the journal Science, researchers led by UNC Lineberger's Qing Zhang, PhD, suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.